Prioritization of genetic variants in the microrna regulome as functional candidates in genome-wide association studies

Human Mutation

Volumn 34, Issue 8, 2013, Pages 1049-1056

  Bulik Sullivan, Brendan ^a   Selitsky, Sara ^a   Sethupathy, Praveen ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Complex disease; Gene regulation; GWAS; MicroRNA; Polymorphism

Indexed keywords

MICRORNA;

ARTICLE; BIOINFORMATICS; CAUSAL ATTRIBUTION; EXON; GENE LOCUS; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOME; HUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

COMPLEX DISEASE; GENE REGULATION; GWAS; MICRORNA; POLYMORPHISM;

BODY HEIGHT; COMPUTATIONAL BIOLOGY; DISEASE; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HELA CELLS; HUMANS; LINKAGE DISEQUILIBRIUM; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; QUANTITATIVE TRAIT LOCI;

EID: 84880512934     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22337     Document Type: Article

References (100)

1. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. 2011. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43:969-976.
2. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491:56-65.
3. Abedin MJ, Imai N, Rosenberg ME, Gupta S. 2011. Identification and characterization of Sall1-expressing cells present in the adult mouse kidney. Nephron. Exp Nephrol 119:e75-e82.
4. Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, Peltonen L, Dermitzakis E, Bonnen PE, et al. 2010. Integrating common and rare genetic variation in diverse human populations. Nature 467:52-58.
5. Arnold M, Ellwanger DC, Hartsperger ML, Pfeufer A, Stumpflen V. 2012. Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways. PloS ONE 7:e36694.
6. Barenboim M, Zoltick BJ, Guo Y, Weinberger DR. 2010. MicroSNiPer: a web tool for prediction of SNP effects on putative microRNA targets. Hum Mutat 31:1223-1232.
7. Barski A, Jothi R, Cuddapah S, Cui K, Roh TY, Schones DE, Zhao K. 2009. Chromatin poises miRNA- and protein-coding genes for expression. Genome Res 19:1742-1751.
8. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
9. Beijersbergen RL, Kerkhoven RM, Zhu L, Carlee L, Voorhoeve PM, Bernards R. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. GenesDev 8:2680-2690.
10. Bhattacharya A, Ziebarth JD, Cui Y. 2012. Systematic analysis of microrna targeting impacted by small insertions and deletions in human genome. PloS ONE 7:e46176.
11. Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ, Vinciguerra M, Rosenthal N, Sciacca S, Pilato M, van Heijningen P, Essers J, et al. 2011. MicroRNA-29 in aortic dilation: implications for aneurysm formation. CircRes 109:1115-1119.
12. Borel C, Antonarakis SE. 2008. Functional genetic variation of human miRNAs and phenotypic consequences. Mamm Genome 19:503-509.
13. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, Cherry JM, Snyder M. 2012. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 22:1790-1797.
14. Brennecke J, Stark A, Russell RB, Cohen SM. 2005. Principles of microRNA-target recognition. PLoS Biol 3:e85.
15. Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF, Hebuterne X, Harel-Bellan A, Mograbi B, et al. 2011. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet 43:242-245.
16. Bruno AE, Li L, Kalabus JL, Pan Y, Yu A, Hu Z. 2012. miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes. BMC Genomics 13:44.
17. Cai X, Hagedorn CH, Cullen BR. 2004. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10:1957-1966.
18. Chen K, Rajewsky N. 2006. Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 38:1452-1456.
19. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W. 2008. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 29:1306-1311.
20. Chi SW, Hannon GJ, Darnell RB. 2012. An alternative mode of microRNA target recognition. Nat Struct Mol Biol 19:321-327.
21. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, et al. 2006. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38:813-818.
22. Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV. 2009. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE 4:e5279.
23. Degner JF, Pai AA, Pique-Regi R, Veyrieras JB, Gaffney DJ, Pickrell JK. De Leon S, Michelini K, Lewellen N, Crawford GE, Stephens M, Gilad Y, Pritchard JK, 2012. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 482:390-394.
24. Deigan KE, Li TW, Mathews DH, Weeks KM. 2009. Accurate SHAPE-directed RNA structure determination. Proc Natl Acad Sci USA 106:97-102.
25. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, Khatun J, Lajoie BR, et al. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74.
26. Ebert MS, Sharp PA. 2012. Roles for microRNAs in conferring robustness to biological processes. Cell 149:515-524.
27. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE. 2011. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473:43-49.
28. Fang Z, Rajewsky N. 2011. The impact of miRNA target sites in coding sequences and in 3′UTRs. PLoS ONE 6:e18067.
29. Forman JJ, Coller HA. 2010. The code within the code: microRNAs target coding regions. Cell Cycle 9:1533-1541.
30. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105.
31. Gaffney DJ, Veyrieras JB, Degner JF, Pique-Regi R, Pai AA, Crawford GE, Stephens M, Gilad Y, Pritchard JK. 2012. Dissecting the regulatory architecture of gene expression QTLs. Genome Biol13:R7.
32. Gamazon ER, Ziliak D, Im HK, LaCroix B, Park DS, Cox NJ, Huang RS. 2012. Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am J Hum Genet 90:1046-1063.
33. Gaulton KJ, Nammo T, Pasquali L, Simon JM, Giresi PG, Fogarty MP, Panhuis TM, Mieczkowski P, Secchi A, Bosco D, Berney T, Montanya E, Mohlke KL, Lieb JD, Ferrer J. 2010. A map of open chromatin in human pancreatic islets. Nat Genet 42:255-259.
34. Gennarino VA, D'Angelo G, Dharmalingam G, Fernandez S, Russolillo G, Sanges R, Mutarelli M, Belcastro V, Ballabio A, Verde P, Sardiello M, Banfi S. 2012. Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res 22:1163-1172.
35. Georges M. 2011. The long and winding road from correlation to causation. Nat Genet 43:180-181.
36. Georges M, Coppieters W, Charlier C. 2007. Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr Opin Genet Dev 17:166-176.
37. Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G, Sun J, Guo AY. 2012. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat 33:254-263.
38. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. 2008. miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154-D158.
39. Haas U, Sczakiel G, Laufer SD. 2012. MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structure. RNA Biol 9:924-937.
40. Halvorsen M, Martin JS, Broadaway S, Laederach A. 2010. Disease-associated mutations that alter the RNA structural ensemble. PLoS Genet 6:e1001074.
41. Hariharan M, Scaria V, Brahmachari SK. 2009. dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics 10:108.
42. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, Ren B, Fu XD, Topol EJ, Rosenfeld MG, Frazer KA. 2011. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 470:264-268.
43. Hiard S, Charlier C, Coppieters W, Georges M, Baurain D. 2010. Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res 38:D640-D651.
44. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106:9362-9367.
45. Hu Z, Bruno AE. 2011. The influence of 3′UTRs on microRNA function inferred from human SNP data. Comp Funct Genomics 2011:910769.
46. Huang S, Wu S, Ding J, Lin J, Wei L, Gu J, He X. 2010. MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions. Nucleic Acids Res 38:7211-7218.
47. Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, Klinger MH, Fricke L, Steinhoff J. 2003. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 33:152-161.
48. Jackson AL, Levin AA. 2012. Developing microRNA therapeutics: approaching the unique complexities. Nucleic Acid Ther 22:213-225.
49. Kim HK, Prokunina-Olsson L, Chanock SJ. 2012. Common genetic variants in mir-1206 (8q24.2) and mir-612 (11q13.3) affect biogenesis of mature mirna forms. PLoS ONE 7:e47454.
50. Kim J, Bartel DP. 2009. Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression. Nat Biotechnol 27:472-477.
51. Kim VN. 2005. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376-385.
52. Kim VN, Han J, Siomi MC. 2009. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10:126-139.
53. Kozomara A, Griffiths-Jones S. 2011. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152-D157.
54. Landi D, Barale R, Gemignani F, Landi S. 2011. Prediction of the biological effect of polymorphisms within microRNA binding sites. Methods Mol Biol 676:197-210.
55. Lee BK, Bhinge AA, Iyer VR. 2011. Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis. Nucleic Acids Res 39:3558-3573.
56. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. 2004. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23:4051-4060.
57. Li J, Liu Y, Xin X, Kim TS, Cabeza EA, Ren J, Nielsen R, Wrana JL, Zhang Z. 2012a. Evidence for positive selection on a number of MicroRNA regulatory interactions during recent human evolution. PLoS Genet 8:e1002578.
58. Li MJ, Wang P, Liu X, Lim EL, Wang Z, Yeager M, Wong MP, Sham PC, Chanock SJ, Wang J. 2012b. GWASdb: a database for human genetic variants identified by genome-wide association studies. Nucleic Acids Res 40:D1047-D1054.
59. Li Y, Nie Y, Cao J, Tu S, Lin Y, Du Y, Li Y. 2012c. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer. Mol Carcinog. Doi:10.1002/mc.21966.
60. Liang H, Landweber LF. 2007. Hypothesis: RNA editing of microRNA target sites in humans? RNA 13:463-467.
61. Liang H, Li WH. 2009. Lowly expressed human microRNA genes evolve rapidly. Mol Biol Evol 26:1195-1198.
62. Lin Y, Nie Y, Zhao J, Chen X, Ye M, Li Y, Du Y, Cao J, Shen B, Li Y. 2012. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility. Carcinogenesis 33:2377-2383.
63. Lu J, Clark AG. 2012. Impact of microRNA regulation on variation in human gene expression. Genome Res 22:1243-1254.
64. Lucks JB, Mortimer SA, Trapnell C, Luo S, Aviran S, Schroth GP, Pachter L, Doudna JA, Arkin AP. 2011. Multiplexed RNA structure characterization with selective 2′-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq). Proc Natl Acad Sci USA 108:11063-11068.
65. Luo X, Yang W, Ye DQ, Cui H, Zhang Y, Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, Tak PP, Tsao BP, Shen N. 2011. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 7:e1002128.
66. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, Johnston WK, Wernig M, Newman J, Calabrese JM, Dennis LM, et al. 2008. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134:521-533.
67. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J, Shafer A, Neri F, et al. 2012. Systematic localization of common disease-associated variation in regulatory DNA. Science 337:1190-1195.
68. Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR. 2007. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci USA 104:13513-13518.
69. Mishra PJ, Mishra PJ, Banerjee D, Bertino JR. 2008. MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell Cycle 7:853-858.
70. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, et al. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-10518.
71. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, Li X, Li H, Kuperwasser N, Ruda VM, Pirruccello JP, Muchmore B, et al. 2010. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466:714-719.
72. Nica AC, Montgomery SB, Dimas AS, Stranger BE, Beazley C, Barroso I, Dermitzakis ET. 2010. Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet 6:e1000895.
73. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ. 2010. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 6:e1000888.
74. Nishinakamura R, Takasato M. 2005. Essential roles of sall1 in kidney development. Kidney Int 68:1948-1950.
75. Onat A, Can G, Hergenc G. 2008. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metab Clin Exp 57:207-214.
76. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, Zhang X, Song JS, Fisher DE. 2008. Chromatin structure analyses identify miRNA promoters. Genes Dev 22:3172-3183.
77. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao K, Kehoe SM, et al. 2009. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 41:882-884.
78. Potkin SG, Macciardi F, Guffanti G, Fallon JH, Wang Q, Turner JA, Lakatos A, Miles MF, Lander A, Vawter MP, Xie X. 2010. Identifying gene regulatory networks in schizophrenia. NeuroImage 53:839-847.
79. Quach H, Barreiro LB, Laval G, Zidane N, Patin E, Kidd KK, Kidd JR, Bouchier C, Veuille M, Antoniewski C, Quintana-Murci L. 2009. Signatures of purifying and local positive selection in human miRNAs. Am J Hum Genet 84:316-327.
80. Richardson K, Lai CQ, Parnell LD, Lee YC, Ordovas JM. 2011. A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics 12:504.
81. Richardson K, Nettleton JA, Rotllan N, Tanaka T, Smith CE, Lai CQ, Parnell LD, Lee YC, Lahti J, Lemaitre RN, Manichaikul A, Keller M, et al. 2012. Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microrna-410 seed site. Am J Hum Genet 92:5-14.
82. Ritz J, Martin JS, Laederach A. 2012. Evaluating our ability to predict the structural disruption of RNA by SNPs. BMC Genomics 13 Suppl 4:S6.
83. Roush S, Slack FJ. 2008. The let-7 family of microRNAs. Trends Cell Biol 18:505-516.
84. Saini HK, Enright AJ, Griffiths-Jones S. 2008. Annotation of mammalian primary microRNAs. BMC Genomics 9:564.
85. Saunders MA, Liang H, Li WH. 2007. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104:3300-3305.
86. Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M. 2012. Linking disease associations with regulatory information in the human genome. Genome Res 22:1748-1759.
87. Schmeier S, Schaefer U, MacPherson CR, Bajic VB. 2011. dPORE-miRNA: polymorphic regulation of microRNA genes. PLoS ONE 6:e16657.
88. Schnall-Levin M, Rissland OS, Johnston WK, Perrimon N, Bartel DP, Berger B. 2011. Unusually effective microRNA targeting within repeat-rich coding regions of mammalian mRNAs. Genome Res 21:1395-1403.
89. Senanayake U, Das S, Vesely P, Alzoughbi W, Frohlich LF, Chowdhury P, Leuschner I, Hoefler G, Guertl B. 2012. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis 33:1014-1021.
90. Sethupathy P, Collins FS. 2008. MicroRNA target site polymorphisms and human disease. Trends Genet 24:489-497.
91. Shen LX, Basilion JP, Stanton VP, Jr. 1999. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci USA 96:7871-7876.
92. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, Bartel DP. 2010. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 38:789-802.
93. Stitzel ML, Sethupathy P, Pearson DS, Chines PS, Song L, Erdos MR, Welch R, Parker SC, Boyle AP, Scott LJ, Margulies EH, Boehnke M, Furey TS, Crawford GE, Collins FS. 2010. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab 12:443-455.
94. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D. 2003. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63:654-661.
95. Sullivan PF. 2012. Puzzling over schizophrenia: schizophrenia as a pathway disease. Nat Med 18:210-211.
96. Thomas LF, Saito T, Saetrom P. 2011. Inferring causative variants in microRNA target sites. Nucleic Acids Res 39:e109.
97. van Rooij E, Purcell AL, Levin AA. 2012. Developing microRNA therapeutics. Circ Res 110:496-507.
98. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, et al. 2010. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20:589-599.
99. Ziebarth JD, Bhattacharya A, Chen A, Cui Y. 2012. PolymiRTS Database 2.0: linking polymorphisms in microRNA target sites with human diseases and complex traits. Nucleic Acids Res 40:D216-D221.
100. Zorc M, Skok DJ, Godnic I, Calin GA, Horvat S, Jiang Z, Dovc P, Kunej T. 2012. Catalog of microRNA seed polymorphisms in vertebrates. PLoS ONE 7:e30737.